George Blumenschein

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study

Jacob Sands, Myung‐Ju Ahn, Aaron Lisberg et al. · Journal of Clinical Oncology · 2025 · 98 citations · Full text

Medicine, Oncology, Pharmacology +16

Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid

Amina Husain, George Blumenschein, Bita Esmaeli · International Journal of Dermatology · 2008 · 92 citations

Medicine, Oncology, Surgery +10

A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD-1 and LAG-3, in patients with unresectable or metastatic neoplasms.

Jason J. Luke, Manish R. Patel, Erika Hamilton et al. · Journal of Clinical Oncology · 2020 · 51 citations

Medicine, Oncology, Pharmacology +17

Merkel Cell Carcinoma of the Eyelid With a Positive Sentinel Node

Bita Esmaeli, Aresu Naderi, Lillie Hidaji et al. · Archives of Ophthalmology · 2002 · 38 citations

Medicine, Oncology, Pathology +12